4DMEDICAL Ltd (4dx) Logo

4DMEDICAL Ltd (4DX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

4DX ASX Chart

Snapshot

4DMedical Limited (4DX) is a medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. This four-dimensional lung imaging technology utilizes proven, patented mathematical models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is based in Melbourne, Australia and Los Angeles, USA.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -16.63%
vs ASX 200 (1yr) -27.48%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 666 of 2,384
Sector Rank 43 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies CAJ / PBP / RAC
EPS -$0.087
DPS $0.00
Book Value Per Share $0.17

Broker Consensus

4DX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Latest 4DMEDICAL Ltd News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Carlton VIC 3053
Website www.4dmedical.com
Registry Link Market Services
Auditor PKF
Date Listed 7 Aug 2020

Upcoming Calendar (Forecasted)

Date Event
27/08/2024 Report (Prelim)
27/08/2024 Report (Annual)
26/02/2025 Report (Interim)

Former Company Names

  • 4DMEDICAL Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

4DX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
04/03/24 Geraldine McGinty Buy +40,000 $0.725 $29,000 Exercise of options
04/03/24 Geraldine McGinty Exercise 40,000 $0.725 $29,000 Exercise of options
04/03/24 Lilian (Lil) Bianchi Buy +40,000 $0.725 $29,000 Exercise of options
04/03/24 Lilian (Lil) Bianchi Exercise 40,000 $0.725 $29,000 Exercise of options
23/01/24 Geraldine McGinty Issued 40,000 $0.790 $31,600 Director remuneration
23/01/24 Lilian (Lil) Bianchi Issued 40,000 $0.790 $31,600 Director remuneration
03/11/23 Andreas Fouras Issued 1,306,100 $0.465 $607,336 Issue of options
18/01/23 John Livingston Issued 636,576 $0.470 $299,190 Issue of options
23/12/22 Andreas Fouras Issued 1,850,914 $0.000 $0 Issue of options
22/03/22 Andreas Fouras Buy +11,277 $0.887 $10,000 On-market trade
07/04/21 Lilian (Lil) Bianchi Issued 3,306 $1.55 $5,124 Participation in share purchase plan
07/04/21 Lusia Guthrie Issued 2,409 $1.55 $3,733 Participation in share purchase plan
07/04/21 Bruce Rathie Issued 9,638 $1.55 $14,938 Participation in share purchase plan

Director Interests

The current holdings of 4DX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Geraldine McGinty 04/03/2024 40,000 N/A 0 N/A
Lilian (Lil) Bianchi 04/03/2024 N/A 93,306 0 N/A
Andreas Fouras 03/11/2023 65,701,465 64,838,000 9,895,426 N/A
Julian Sutton 30/06/2023 297,786 183,014 6,205,162 N/A
Robert Figlin 30/06/2023 519,943 N/A N/A N/A
John Livingston 30/06/2023 N/A 1,925,352 636,576 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 16, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Velocimetry Consulting Pty Ltd 64,838,000 18.79%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd 18,106,697 5.25%
HSBC Custody Nominees (Australia) Limited 7,580,063 2.20%
Ryder Innovation Fund Lp 6,290,475 1.82%
National Nominees Limited 3,663,160 1.06%
J P Morgan Nominees Australia Pty Limited 3,038,117 0.88%
HSBC Custody Nominees (Australia) Limited – A/C 2 2,884,390 0.84%
Alex Petrou & Christine Petrou 2,484,471 0.72%
Mr Damen Diamantopoulos 2,470,000 0.72%
Netwealth Investments Limited 2,340,650 0.68%
Citicorp Nominees Pty Limited 2,083,306 0.60%
Mrs Irene Wai-Ping Lee & Miss Yvonne Lee & Mr Wilson Lee 1,841,379 0.53%
John Livingston Pty Ltd 1,817,243 0.53%
Endless Smiles Pty Ltd 1,500,000 0.43%
BNP Paribas Nominees Pty Ltd 1,480,089 0.43%
Mr Dev Jayram 1,433,262 0.42%
Wal Assets Pty Ltd 1,411,487 0.41%
Chapter 5 Pty Ltd 1,220,697 0.35%
Jianwen Xiao 1,216,176 0.35%
AAX Pty Ltd 1,200,000 0.35%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 1,922 2,626 1,253 2,556 429 8,786

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Helen Fouras 15/12/2023 65,701,465 16.81
Velocimetry Consulting Pty Ltd 15/12/2023 65,701,465 16.81
Andreas Fouras 15/12/2023 65,701,465 16.81

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
15-12-23 Andreas Fouras 648,696 19.2 16.8
15-12-23 Velocimetry Consulting Pty Ltd 648,696 19.2 16.8
15-12-23 Helen Fouras 648,696 19.2 16.8

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.670 30 June
2022 $0.590 30 June
2021 $1.23 30 June
4DX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.